| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immunovant, Inc. | Chief Legal Officer | Common Stock | 150K | $4.11M | $27.38 | 18 Dec 2025 | Direct |
| Immunovant, Inc. | Chief Legal Officer | Stock Option (right to buy) | 71.5K | 01 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | 18 Dec 2025 | 2 | -$291K | 4 | Chief Legal Officer | 19 Dec 2025, 16:05 |
| IMVT | Immunovant, Inc. | 01 Apr 2025 | 2 | $0 | 4 | Chief Legal Officer | 03 Apr 2025, 16:55 |
| IMVT | Immunovant, Inc. | 16 Dec 2024 | 2 | $0 | 4 | Chief Legal Officer | 18 Dec 2024, 17:02 |
| IMVT | Immunovant, Inc. | 16 Dec 2024 | 0 | $0 | 3 | Chief Legal Officer | 18 Dec 2024, 17:01 |